Search | TVST | ARVO Journals

Showing 1 – 20 of 27

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2023

Adalimumab in the treatment of refractory non-infectious scleritis: 6-month outcomes

Ian Yeung; Emilia Agata Bober; Kristina Frain; Majid Fotuhi; Jonathan Virgo; Edward Hindle; Jianfei Ma; Peter Addison; Narciss Okhravi; William Tucker; Mark Westcott; Carlos Pavesio; Richard W J Lee

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):3542.

Articles October 2019

Modelling Macular Edema: The Effect of IL-6 and IL-6R Blockade on Human Blood–Retinal Barrier Integrity In Vitro

PDF

Marina Mesquida; Faye Drawnel; Philippa J. Lait; David A. Copland; Madeleine L. Stimpson; Victor Llorenç; Maite Sainz de la Maza; Alfredo Adan; Gabriella Widmer; Pamela Strassburger; Sascha Fauser; Andrew D. Dick; Richard W. J. Lee; Blanca Molins
TAGS: interleukin 6 receptor, interleukin-6, macular edema, personal integrity, blood-retinal barrier
Trans. Vis. Sci. Tech.. 2019; 8(5):32. https://doi.org/10.1167/tvst.8.5.32

Includes: Supplemental Content

ARVO Annual Meeting Abstract July 2019

Oral immunosuppression practice for inflammatory eye disease: A one-year analysis of prescriptions at Moorfields Eye Hospital

Tasanee Braithwaite; Jason Delisser; Jonathan Virgo; Edward Hindle; William Tucker; Harry Petruskin; Angela L Rees; Dhanes Thomas; Mark C Westcott; Peter Addison; Carlos Pavesio; Richard W J Lee; Alastair K Denniston; Narciss Okhravi

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):3527.

ARVO Annual Meeting Abstract July 2018

Clinical spectrum of vitreoretinal lymphoma and its association with MyD88 L265P mutation

Ester Carreno; Timothy Clench; Laura R Steeples; Serena Salvatore; Richard W. J. Lee; Andrew D Dick; Joya Pawade

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):5578.

ARVO Annual Meeting Abstract July 2018

The negative psychosocial impact of thyroid eye disease - comparing results from the CIRTED trial with strabismus and other facially disfiguring conditions.

Shokufeh Tavassoli; Rathie Rajendram; Victoria Wilson; Paul White; Jimmy Uddin; Colin Dayan; Richard W. J. Lee; Sue Jackson

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):5618.

ARVO Annual Meeting Abstract June 2017

The suppressive effect of the epigenetic drug, Givinostat (ITF2357), on peripheral blood leukocytes from uveitis patients

Lauren P Schewitz-Bowers; Philippa J P Lait; Wei Chen; Ester Carreno; Xiao Hu; Zhiyu Li; Jing Chen; Kara M Ponsford; Andrew D Dick; Lai Wei; Rachel R Caspi; Richard W J Lee; Benjamin Chaigne-Delalande

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):510.

ARVO Annual Meeting Abstract June 2017

Quantification of flow at baseline and follow-up in uveitic and non-age-related macular degeneration choroidal neovascular membranes (CNVM) using Optical Coherence Tomography-Angiography (OCT-A).

Tomas Burke; Ester Carreno; Clare Bailey; Richard W J Lee; Andrew D Dick; Adam H Ross

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):1643.

ARVO Annual Meeting Abstract June 2017

In vitro effects of IL-6 and IL-6R blockade on the blood-retinal barrier

Marina Mesquida; David A Copland; Philippa J P Lait; Victor Llorens; Maite Sainz De La Maza; Alfredo Adan Civera; Andrew D Dick; Richard W J Lee; Blanca Molins

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):5728.

ARVO Annual Meeting Abstract June 2017

New staging of Acute Posterior Multifocal Placoid Pigment Epiteliopathy by using multimodal imaging

Ester Carreno; Tomas Burke; Colin Chu; Serena Salvatore; Richard W J Lee; Clare Bailey; Andrew D Dick; Adam H Ross

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):5995.

ARVO Annual Meeting Abstract September 2016

In vitro effects of interleukin-6 on the outer blood-retinal barrier

Marina Mesquida; Philippa J P Lait; David Alexander Copland; Jian Liu; Victor Llorens; Maite Sainz De La Maza; Alfredo Adan Civera; Andrew D Dick; Richard W J Lee; Blanca Molins

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):4184.

ARVO Annual Meeting Abstract June 2015

An exploratory study of ranibizumab for treatment of quiescent uveitic patients with refractory cystoid macular oedema (The LIMO Study)

Simona Degli Esposti; Ahmed Samy; Oliver Comyn; Gary S Rubin; Ana Quartilho; Wen Xing; Catey Bunce; Richard W J Lee; Narciss Okhravi; Michel Michaelides

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):6165.

ARVO Annual Meeting Abstract June 2015

Evaluation of retinal microvasculature in uveitic macular edema using Optical Coherence Tomography Angiography.

Noa Fernandez Ledo; Dawn A Sim; Pearse Andrew Keane; Adnan Tufail; Catherine A Egan; Marcus Fruttiger; Nelida Sanz; Carlos E Pavesio; Richard W J Lee; Mark C Westcott

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):6172.

ARVO Annual Meeting Abstract June 2015

Intermediate (CD14 ++ CD16 + ) monocytes are expanded in non-infectious uveitis patients and have a reduced capacity to drive Th17 differentiation.

Emily Louisa Williams; Baoying Liu; Ashwin Dhanda; Philippa J P Lait; Lauren P Schewitz-Bowers; Peter Collins; Andrew D Dick; Robert B Nussenblatt; Richard W J Lee

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):852.

ARVO Annual Meeting Abstract June 2015

Expression kinetics of Glucocorticoid Receptor Isoforms Predicts Treatment Response to Glucocorticoids in Uveitis patients

Cristhian A Urzua; Han Si; Baoying Liu; Philippa Lait; Richard W J Lee; Annelise Goecke; Robert B Nussenblatt

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):853.

ARVO Annual Meeting Abstract June 2015

IL-10 expression by Th17 cells correlates with their response to glucocorticoids

Philippa J P Lait; Lauren P Schewitz-Bowers; Emily Louisa Williams; Ester Carreno; Andrew D Dick; Richard W J Lee

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):866.

ARVO Annual Meeting Abstract June 2015

Prospective case series of Ranibizumab for the treatment of inflammatory and idiopathic choroidal neovascular membranes.

Ester Carreno; Tanya Moutray; Kostantinos Fotis; Richard W J Lee; Andrew D Dick; Adam H Ross; Clare Bailey

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):196.

ARVO Annual Meeting Abstract June 2015

A randomized 36-week crossover trial comparing ranibizumab and bevacizumab for diabetic macular edema

Henry Wiley; Clare Bailey; Catherine A Cukras; Glenn J Jaffe; Richard W J Lee; Erin Loken; Catherine Meyerle; Darby J.S. Thompson; Wai T Wong; Frederick L Ferris

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):3149.

ARVO Annual Meeting Abstract June 2015

Novel anti-TNF-α antibody mimetic to treat ocular inflammation

David A Copland; Hanieh Khalili; Richard W J Lee; Peng Tee Khaw; Steve Brocchini; Andrew D Dick

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):3210.

ARVO Annual Meeting Abstract June 2015

Depot Indocyanine Green Dye for in vivo visualization of infiltrating leukocytes

Dawn A Sim; Colin J Chu; Michael B Powner; Senthil Selvam; Adnan Tufail; Catherine A Egan; James W B Bainbridge; Richard W J Lee; Andrew D Dick; Marcus Fruttiger

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):4117.

Immunology and Microbiology January 2015

Levels of Blood CD1c + mDC1 and CD1c hi mDC1 Subpopulation Reflect Disease Activity in Noninfectious Uveitis

PDF

Ping Chen; William Tucker; Susan Hannes; Baoying Liu; Han Si; Ankur Gupta; Richard W. J. Lee; H. Nida Sen; Robert B. Nussenblatt
TAGS: uveitis
Invest. Ophthalmol. Vis. Sci.. 2015; 56(1):346-352. https://doi.org/10.1167/iovs.14-15416

1 2

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Adalimumab in the treatment of refractory non-infectious scleritis: 6-month outcomes

Modelling Macular Edema: The Effect of IL-6 and IL-6R Blockade on Human Blood–Retinal Barrier Integrity In Vitro

Oral immunosuppression practice for inflammatory eye disease: A one-year analysis of prescriptions at Moorfields Eye Hospital

Clinical spectrum of vitreoretinal lymphoma and its association with MyD88 L265P mutation

The negative psychosocial impact of thyroid eye disease - comparing results from the CIRTED trial with strabismus and other facially disfiguring conditions.

The suppressive effect of the epigenetic drug, Givinostat (ITF2357), on peripheral blood leukocytes from uveitis patients

Quantification of flow at baseline and follow-up in uveitic and non-age-related macular degeneration choroidal neovascular membranes (CNVM) using Optical Coherence Tomography-Angiography (OCT-A).

In vitro effects of IL-6 and IL-6R blockade on the blood-retinal barrier

New staging of Acute Posterior Multifocal Placoid Pigment Epiteliopathy by using multimodal imaging

In vitro effects of interleukin-6 on the outer blood-retinal barrier

An exploratory study of ranibizumab for treatment of quiescent uveitic patients with refractory cystoid macular oedema (The LIMO Study)

Evaluation of retinal microvasculature in uveitic macular edema using Optical Coherence Tomography Angiography.

Intermediate (CD14 ++ CD16 + ) monocytes are expanded in non-infectious uveitis patients and have a reduced capacity to drive Th17 differentiation.

Expression kinetics of Glucocorticoid Receptor Isoforms Predicts Treatment Response to Glucocorticoids in Uveitis patients

IL-10 expression by Th17 cells correlates with their response to glucocorticoids

Prospective case series of Ranibizumab for the treatment of inflammatory and idiopathic choroidal neovascular membranes.

A randomized 36-week crossover trial comparing ranibizumab and bevacizumab for diabetic macular edema

Novel anti-TNF-α antibody mimetic to treat ocular inflammation

Depot Indocyanine Green Dye for in vivo visualization of infiltrating leukocytes

Levels of Blood CD1c + mDC1 and CD1c hi mDC1 Subpopulation Reflect Disease Activity in Noninfectious Uveitis

To View More...

You must be signed into an individual account to use this feature.